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TITLE OF CASE Do not include “a case report” 
Neurodegenerative Disorder Masquerading as Psychosis in a Forensic Psychiatry Setting 
SUMMARY Up to 150 words summarising the case presentation and outcome (this 
will be freely available online) 
A man presenting in his 50s, following conviction for a non-violent crime, to forensic psychiatric 
services, and then to a neuropsychiatry service with an unusual presentation of psychosis; 2nd 
person auditory hallucinations, grandiose delusions and somatic delusions. Detailed collateral 
and family history revealed a background of progressive cognitive deficit and a family history of 
motor neurone disease. MRI brain revealed asymmetrical parieto-occipital volume loss and 
genetic testing demonstrated a pathogenic expansion of the chromosome 9 open reading frame 
72 (C9ORF72) gene consistent with familial frontotemporal dementia caused by a 
hexanucleotide repeat expansion at C9ORF72; a recently discovered cause for familial 
frontotemporal dementia/motor neurone disease. 
 
This form of frontotemporal dementia should be considered as an important potential 
differential diagnosis for patients presenting with psychotic symptoms in later life, in whom a 
detailed family history and thorough cognitive assessment is essential. 
BACKGROUND Why you think this case is important – why did you write it up? 
There is a broad differential diagnosis for patients presenting with psychotic symptoms, 
encompassing primary psychiatric illness, effects of toxic drugs, infectious processes, metabolic 
diseases, epilepsy and neurodegenerative disorders. Psychotic symptoms are common in 
patients with Alzheimer’s Dementia[1, 2]. In the frontotemporal dementia spectrum, psychotic 
symptoms have probably been under-recognised[3] and may signal particular pathologies: in 
particular, frontotemporal dementia and motor neurone disease associated with mutations in 
the recently identified gene C9ORF72[4]. 
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We present the case of a man presenting in a forensic psychiatry setting with psychotic 
symptoms caused by a pathological expansion in the C9ORF72 gene. 
CASE PRESENTATION Presenting features, medical/social/family history 
The patient is a man who presented while in his 50s, convicted for a non-violent crime. While 
being conveyed to the prison following an appeal against this conviction, he began to complain 
of psychotic experiences. He described hearing the voice of God in his ear telling him that his 
appeal against the conviction had been successful and later claimed that he was telepathic. He 
was transferred from prison to a forensic psychiatry unit for a seven month period of 
assessment. 
 
The only relevant past medical history was poorly-controlled hypertension and there was no 
history of psychiatric disease or alcohol or drug misuse. He made no effort to conceal the crimes 
for which he was convicted and had a brief incarceration for a similar crime less than one year 
before.  He was married with children and there was no known family history of psychiatric or 
cognitive disease. There was, however, a family history of motor neurone disease, with one of 
the patient’s five siblings – an older brother – manifesting symptoms of the condition in his mid-
50s before developing swallowing and speech problems and dying from respiratory 
complications at around 60 years of age. He is not known to have had any cognitive problems. 
 
At no point did he complain of affective symptoms or cognitive impairment but he suffered from 
a number of apparent psychotic symptoms. He continued to intermittently report that he could 
hear the voice of God in his ear, reassuring him by offering a letter which would overturn his 
conviction and he would be seen overtly responding to this auditory hallucination. He planned 
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to go to Cyprus where, he believed, he would become President. He also described mild 
intermittent headaches which he attributed variously to God and to the courts who, he 
believed, had been corrupt and prejudiced against him. In addition, he described having a 'small 
man' in his bowel who helped with his digestion. 
 
These symptoms fluctuated in intensity, seemingly worse when called to repeat court 
appearances and he did not seem distressed by them; this, combined with performance on a 
neuropsychometric test for malingering worse than expected by chance, led to some suspicion 
of malingering. Both sulpride and aripiprazole were trialled but there was little response to 
these. 
 
Problems with his cognition – naming problems – were detected more than twelve months after 
the onset of psychotic symptoms and he was referred to a specialist neuropsychiatry service. 
Collateral history was obtained from his wife, who had noted changes over the preceding five 
years with reduced empathy, increased appetite for sweet foods and irritability. She also 
reported that he had developed a fixed routine from which he had difficulty deviating and had 
begun to use a satellite-navigation system to guide him when on familiar routes. His short and 
long-term episodic memory, language ability and numeracy skills seemed unchanged. In 
addition, his wife explained that he had developed a new religious preoccupation. 
 
On mental state examination, he presented as reasonably kempt and casually dressed. He made 
good eye contact and allowed the establishment of a superficially friendly but limited rapport. 
He seemed disorganised and perplexed on approach, although was not anxious or distressed, 
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and his speech was tangential and pressured. His mood was subjectively and objectively 
euthymic and there were no biological symptoms of depression though his affect was flat. He 
responded overtly throughout interview to apparent auditory hallucinations and described 
hearing the voice of God in his ear and he also possessed delusional beliefs about his conviction 
and having a man in his bowel who aided digestion. He lacked any insight into the abnormal 
nature of these experiences. 
 
Neurological examination revealed no cranial or peripheral nerve deficit. There was a positive 
pout reflex but other primitive reflexes were absent. Cognitive examination demonstrated 
frontal lobe deficits - inability to complete the Luria three-step task or alternating hand 
movements and difficulty interpreting proverbs. He had difficulty naming items but his reading 
was normal and there was no significant episodic memory impairment. Parietal lobe testing 
demonstrated mild difficulty copying hand gestures and slowness in recognising degraded 
pictures and letters but no ideomotor apraxia or difficulties with arithmetic. 
INVESTIGATIONS If relevant 
Routine blood tests to look for common causes of cognitive impairment and psychosis, including 
thyroid function, calcium, vitamin B12 and folate were normal. HIV, Syphilis antibodies and 
Whipple's PCR were negative and a screen of autoimmune causes of psychosis - ANA, ANCA, 
Anti-GAD, Anti-glycine, NMDA-receptor antibody and voltage-gated potassium channel antibody 
- revealed no abnormality. 
 
An MRI scan of his brain (Fig. 1-3) demonstrated widened subdural spaces over both cerebral 
convexities, greater on the right side, with volume loss focused on the right parietal and 
occipital cortices. Hippocampal volume was reduced, greater on the right side. There was 
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minimal signal abnormality in the basal ganglia and deep cerebral white matter of both 
hemispheres suggestive of small vessel disease. An electroencephalogram was also performed 
which was normal. 
 
Neuropsychological testing revealed a verbal IQ of 92 – in the average range – on the Wechsler 
Adult Intelligence Scale (WAIS-III) and a low-average performance IQ, 80. These demonstrated a 
moderate decline relative to estimates of his optimal level of functioning. Visual memory and 
naming skills were weak and there was evidence of executive dysfunction and cognitive slowing. 
DIFFERENTIAL DIAGNOSIS If relevant 
 
TREATMENT If relevant  
 
OUTCOME AND FOLLOW-UP 
The clinical and imaging findings were supportive of a diagnosis of frontotemporal lobar 
degeneration. In order to delineate the underlying aetiology, a lumbar puncture was proposed 
but the patient refused to undergo this procedure. Given the family history of motor neurone 
disease, genetic testing was undertaken with PCR and then Southern Blotting to identify a 
pathogenic expansion of the chromosome 9 open reading frame 72 (C9ORF72) gene. This 
confirmed the presence of a hexanucleotide repeat expansion at C9ORF72, providing the 
underlying genetic diagnosis for this case of frontotemporal dementia presenting with psychotic 
symptoms in a forensic setting. 
DISCUSSION Include a very brief review of similar published cases  
This case is of a male in his 50s presenting with psychotic symptoms with a somatic focus and 
cognitive decline caused by frontotemporal dementia (FTD) due to a hexanucleotide repeat 
expansion at C9ORF72 (C9+). The case demonstrates a rare but important cause of psychotic 
symptoms and we feel that this should be an important potential differential diagnosis in 
patients presenting with psychotic symptoms in later life, especially in those with a positive 
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family history of young-onset dementia or motor neurone disease (MND) and in those with 
cognitive decline. 
 
The role of a hexanucleotide repeat expansion at C9ORF72 in families with FTD with or without 
MND was only recently identified[5, 6] and represented a significant development in research 
into neurodegenerative disorders. 
 
One study found that C9+ accounted for 11.7% of familial FTD[5] while other studies have 
quoted a frequency of 28.6% in those patients with FTD and a positive family history of early-
onset dementia or MND[7]. 
 
Patients with C9+ present most commonly with symptoms of behavioural variant FTD (bvFTD); 
around 48 - 50% in most case series[8, 9] but can present with a clinical picture of FTD-MND in 
19-36% of cases or primary progressive aphasia in up to 19% of cases[10]. 
 
As in this case, the mean age of onset of FTD in patients with C9+ is reported as between 55.0 – 
59.2 years and the mean duration of disease from onset until death of 7.6 – 9.5 years[7, 9, 10]. 
Survival is worse and the cognitive decline is more rapid in people with C9+ FTD than those with 
non-carrier FTD[11]. 
 
In our case, a detailed family history from a collateral source was instructive in clarifying the 
likely diagnosis and evidence suggests that a family history of young-onset dementia or MND is 
present in around two-thirds of patients with C9+; more than one relative is affected in 39% of 
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cases [4]. 
 
It is well established that psychotic symptoms are seen in all forms of dementia[12] but there is 
strengthening evidence that psychotic symptoms are more common in those patients with FTD-
MND[13] and C9+ FTD. One study suggested that 38% of patients with C9+ FTD experienced 
psychotic symptoms compared to 4% of those with non-carrier FTD [4]. Furthermore, as in this 
case, these are frequently the presenting symptoms: a study comparing early neuropsychiatric 
symptoms in 15 patients with (bvFTD) caused by C9+ versus 48 non-carrier bvFTD patients 
showed that delusions were an initial presenting symptom in 21.4% of the C9+ patients 
compared to none of the non-carrying patients[8].  
 
Other presenting neuropsychiatric symptoms frequently seen early in C9+ FTD are disinhibition 
(63%), apathy (49%), disorganisation (45%), episodic memory loss (44%) and anxiety and 
agitation (40%). Neuropsychological testing shows executive dysfunction (100%), verbal or visual 
episodic memory loss (87%) and apraxia (57%). Neurological examination reveals brisk deep-
tendon reflexes in 40% of early cases, progressing to clinical evidence of MND in the majority[9]. 
 
Neuroimaging demonstrates atrophy in medial, ventral and dorsal frontal, anterior insular and 
anterior temporal lobes. Greater parietal and bilateral thalamic atrophy was seen in C9+ bvFTD 
than in non-carriers[8], and the parietal atrophy, especially on the right side, is notable in the 
MRI scan images of our case. Group brain morphometry studies have implicated a culprit 
cortico-thalamo-cerebellar network in the pathogenesis of C9+ FTD[9]: the finding of abnormal 
body schema processing in patients with C9+ FTD[14] may reflect disintegration of this brain 
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network and provide a substrate for the (often somatically focused) neuropsychiatric symptoms 
in these patients. There is little evidence for the effects of C9+ on CSF parameters; one study 
found that all patients had normal levels of CSF cells, protein, glucose, aBeta and S100 and only 
one had an abnormal CSF Tau level[9]. 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required 
field 
 C9ORF72 hexanucleotide repeat expansion-related frontotemporal dementia is an 
unusual and recently discovered genetic syndrome, which is a rare but important 
differential diagnosis for psychotic symptoms. 
 Doctors working in mental health, forensic, geriatric medicine and neurology settings 
need to be vigilant for symptoms of cognitive impairment in unusual presentations of 
psychosis in older people. 
 This case demonstrates the value of thorough collateral history and a focus on family 
history when rare neuropsychiatric presentations are encountered. 
 Revised July 2013  Page 9 of 11 
 
REFERENCES Vancouver style (Was the patient involved in a clinical trial? Please 
reference related articles) 
1) Vilalta-Franch J, Lopez-Pousa S, Calvo-Perxas L et al. Psychosis of Alzheimers Disease: 
prevalence, incidence, persistence, risk factors, mortality. Am J Geriatr Psychiatry Published 
Online First:18 January 2013. doi: 10.1016/j.jagp.2013.01.051 
2) Ropacki SA, Jeste DV. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a 
review of 55 studies published from 1990 to 2003. Am J Psychiatry 2005;162:2022-30 
3) Omar R, Sampson EL, Loy CT et al. Delusions in frontotemporal lobar degeneration. J Neurol 
2009;256:600-7 
4) Snowden JS, Rollinson S, Thompson JC et al. Distinct clinical and pathological characteristics of 
frontotemporal dementia associated with C9ORF72 mutations. Brain 2012;135:693-708 
5) Dejesus-Hernandez M, Mackenzie IR, Boeve BF et al. Expanded GGGGCC hexanucleotide 
repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 
2011;72:245-56 
6) Renton AE, Majounie E, Waite A et al. A hexanucleotide repeat expansion in C9ORF72 is the 
cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257-68 
7) Dobson-Stone C, Hallupp M, Bartley L et al. C9ORF72 repeat expansion in clinical and 
neuropathologic frontotemporal dementia cohorts. Neurology 2012;79:995-1001 
8) Sha S, Takada L, Rankin K et al. Frontotemporal dementia due to C9ORF72 mutations: Clinical 
and Imaging Features. Neurology 2012;79:1002-11 
9) Mahoney C, Beck J, Rohrer J et al. Frontotemporal dementia with the C9ORF72 
hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. 
Brain 2012;135:736-50 
10) Simón-Sánchez J, Dopper E, Cohn-Hokke P et al. The clinical and pathological phenotype of 
 Revised July 2013  Page 10 of 11 
C9ORF72 hexanucleotide repeat expansions. Brain 2012;135:723-35 
11) Irwin D, McMillan C, Brettschneider J et al. Cognitive decline and reduced survival in C9orf72 
expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg 
Psychiatry 2013; 84:163-69 
12) Levy ML, Miller BL, Cummings JL et al. Alzheimer disease and frontotemporal dementias: 
behavioral distinctions. Arch Neurol 1996;53:687–90 
13) Lillo P, Garcin B, Hornberger M et al. Neurobehavioural features in frontotemporal dementia 
with amyotrophic lateral sclerosis. Arch Neurol 2010;67:826-30 
14) Downey LE, Mahoney CJ, Rossor MN et al. Impaired self-other differentiation in 
frontotemporal dementia due to the C9ORF72 expansion. Alzheimers Res Ther 2012;4:42 
 
FIGURE/VIDEO CAPTIONS figures should NOT be embedded in this document 
Figure 1-3 – Coronal sections of MRI Brain Scan: T1 weighted images. 
 
PATIENT’S PERSPECTIVE Optional but encouraged 
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